Table 2 Characteristics of patients with distant metastases at presentation
From: PSMA expression level predicts differentiated thyroid cancer aggressiveness and patient outcome
ID | Sex | Age (year) | Side of primary tumor | Histological subtype | Vascular invasion | Status of surgical margins | T parameter | N parameter | M parameter (site) | PSMA expression (%) | Recurrence, time in months | RAI refractoriness, time in months | Status at last follow-up, time in months |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
#26 | F | 78 | Right | Poorly diff | Yes | Free | pT3 | pNx/cN0 | pM1 (bone) | 40 | Yes, 12 | Yes, 24 months | No disease-free, 31 |
#24 | F | 79 | Left | Well diff | Yes | Free | pT2 | pN0/cN0 | pM1 (bone) | 40 | Yes, 1 | No | No disease-free, 37 |
#51 | M | 60 | Right | Well diff | No | Free | pT1 | pNx/cN0 | pM1 (bone) | 40 | Yes, 27 | Yes, 27 | No disease-free, 44 |
#13 | F | 71 | Right | Well diff | Yes | Involved | pT3 | pN0/cN0 | pM1 (bone)/cM1 (bone, lung) | 40 | Yes, 6 | Yes, 16 | No disease-free, 38 |
#33 | M | 52 | Left | Well diff | Yes | Involved | pT1a | pNx/cN0 | pM1 (bone) | 40 | Yes, 10 | Yes, 32 | No disease-free, 53 |
#45 | M | 78 | Right | Well diff | Yes | Involved | pT3 | pN0/cN0 | pM1 (bone) | 70 | Yes, 4 | Yes, 2 | No disease-free, 15 |
#29 | M | 47 | Right | Poorly diff | Yes | Involved | pT4 | pN0/cN0 | pM1 (bone) | 80 | Yes, 5 | Yes, 5 | No disease-free, 6 |
#57 | F | 80 | Left | Poorly diff | Yes | Free | pT3 | pN1a/cN1 (mediastinum) | cM1 (lung, liver) | 80 | Yes, 5 | Yes, 3 | No disease-free, 26 |
#36 | F | 76 | Right | Well diff | Yes | Free | pT3 | pNx/cN0 | pM1(bone) | 80 | Yes, 13 | Yes, 5 | No disease-free, 87 |